Chugai Pharmaceutical Co Ltd (4519.T)

4519.T on Tokyo Stock Exchange

23 May 2018
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Domestic segment is engaged in the sale of pharmaceutical products manufactured by the Company through its nationwide appointed stores. This segment is also involved in the research, development, transportation and storage of pharmaceutical products, as... (more)


Beta: 0.64
Market Cap(Mil.): ¥2,650,113.00
Shares Outstanding(Mil.): 559.69
Dividend: 29.00
Yield (%): 1.16


  4519.T Industry Sector
P/E (TTM): 44.56 30.95 32.75
EPS (TTM): 106.25 -- --
ROI: 8.65 14.84 14.38
ROE: 8.97 16.34 16.07

BRIEF-Chugai Pharmaceutical To Invest 25 Bln Yen Into A Singapore Research Center By 2021-Nikkei‍​

* CHUGAI PHARMACEUTICAL LOOKS TO INVEST SOME 25 BILLION YEN INTO A SINGAPORE RESEARCH CENTER FOR BIOPHARMACEUTICALS BY 2021 - NIKKEI‍​ Source text :(s.nikkei.com/2CitZyn) Further company coverage: (bangalore.newsroom@thomsonreuters.com)

29 Dec 2017

BRIEF-Chiome Bioscience says termination of joint research contract

* Says it announces termination of candidate antibody related joint research contract, which was signed between the co and CHUGAI PHARMACEUTICAL CO LTD, as the contract has expired on Dec. 31

18 Dec 2017

BRIEF-Chugai Pharmaceutical says change of chief executive officer

* Says it names current president and chief operating officer Tatsuro Kosaka as chief executive officer and president, effective late March 2018

12 Dec 2017

Earnings vs. Estimates